Singapore markets closed
Straits Times Index
3,292.93 -3.96 (-0.12%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,475.92 +268.79 (+1.48%) FTSE 100
8,213.49 +41.34 (+0.51%) Bitcoin USD
62,906.89 +3,563.25 (+6.00%) CMC Crypto 200
1,365.79 +88.81 (+6.95%)
Prothena Corporation plc (PRTA)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 22.04 |
| Open | 22.99 |
| Bid | 22.88 x 200 |
| Ask | 22.95 x 400 |
| Day's range | 22.74 - 23.70 |
| 52-week range | 19.65 - 79.65 |
| Volume | |
| Avg. volume | 626,303 |
| Market cap | 1.232B |
| Beta (5Y monthly) | 0.24 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Earnings Preview: Prothena (PRTA) Q1 Earnings Expected to Decline
Prothena (PRTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
CHMP to Delay Nod on Biogen (BIIB), Eisai's Alzheimer's Drug
Per Biogen (BIIB)/Eisai, the delay in CHMP recommendation for lecanemab is entirely related to procedural reasons at the EMA and is not related to the companies' regulatory filing.
- Simply Wall St.
Prothena Full Year 2023 Earnings: Beats Expectations
Prothena ( NASDAQ:PRTA ) Full Year 2023 Results Key Financial Results Revenue: US$91.4m (up 70% from FY 2022). Net...
© 2024 Yahoo. All rights reserved.